Krone, Charles L. External Entity

Publications

Sort by

Selected publications

  • A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.  Inflammatory bowel diseases2006 Academic Article GET IT
    Times cited: 81

Other